JPWO2009044883A1 - モルヒナン誘導体またはその薬理学的に許容される酸付加塩を有効成分とする皮膚性状改善治療薬 - Google Patents
モルヒナン誘導体またはその薬理学的に許容される酸付加塩を有効成分とする皮膚性状改善治療薬 Download PDFInfo
- Publication number
- JPWO2009044883A1 JPWO2009044883A1 JP2009536121A JP2009536121A JPWO2009044883A1 JP WO2009044883 A1 JPWO2009044883 A1 JP WO2009044883A1 JP 2009536121 A JP2009536121 A JP 2009536121A JP 2009536121 A JP2009536121 A JP 2009536121A JP WO2009044883 A1 JPWO2009044883 A1 JP WO2009044883A1
- Authority
- JP
- Japan
- Prior art keywords
- skin
- therapeutic agent
- acid addition
- pharmacologically acceptable
- addition salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Abstract
Description
[1]下記一般式(I)
[2]一般式(I)において、R1がシクロプロピルメチル、シクロブチルメチル、シクロペンチルメチルまたはシクロヘキシルメチルであり、R2がメチル、エチルまたはプロピルである[1]に記載の皮膚性状改善治療薬。
[3]一般式(I)で表される化合物が(−)−17−(シクロプロピルメチル)−3,14β−ジヒドロキシ−4,5α−エポキシ−6β[N−メチル−トランス−3−(3−フリル)アクリルアミド]モルヒナンである[1]に記載の皮膚性状改善治療薬。
Aは−XC(=Y)−、−XC(=Y)Z−、−X−、または−XSO2−(ここでX、YおよびZは各々独立してNR4、SまたはOを表す。ここでR4は水素、炭素数1から5の直鎖もしくは分岐アルキル、または炭素数6から12のアリールを表し、式中R4が2以上の場合は互いに同一または異なっていてもよい)を表す。
R8は水素、炭素数1から5のアルキル、または炭素数1から5のアルカノイルを表す。
下記の構造式(II)で表される(−)−17−(シクロプロピルメチル)−3,14β−ジヒドロキシ−4,5α−エポキシ−6β[N−メチル−トランス−3−(3−フリル)アクリルアミド」モルヒナン塩酸塩(化合物1)の2.5μgを含む溶液をゼラチン皮膜の軟カプセルに封入し、経口剤とした。この経口剤2カプセル(5.0μg)を血液透析患者における既存治療抵抗性のそう痒患者2名が服用したところ、1名(女性、79歳)は服薬開始より、かゆみ軽減とともに全体的に肌(特に足)がすべすべになり、肌がきれいになった。1名(男性、69歳)は顔色・肌質がかなり悪かったが、同経口剤を服薬開始後、顔のかさつきが減り顔色もよくなった。1名は同経口剤を服用開始4、5日後に手首から肩および胸のあたりの痒みが治まったころから肌がしっとりし、服用終了後、痒みを再び感じた頃に肌がかさかさしてきた。
Claims (4)
- 一般式(I)において、R1がシクロプロピルメチル、シクロブチルメチル、シクロペンチルメチルまたはシクロヘキシルメチルであり、R2がメチル、エチルまたはプロピルである請求項1に記載の皮膚性状改善治療薬。
- 一般式(I)で表される化合物が(−)−17−(シクロプロピルメチル)−3,14β−ジヒドロキシ−4,5α−エポキシ−6β[N−メチル−トランス−3−(3−フリル)アクリルアミド]モルヒナンである請求項1に記載の皮膚性状改善治療薬。
- 請求項1に記載の一般式(I)で表される化合物またはその薬理学的に許容される酸付加塩の有効量を皮膚性状を有する患者に投与することを含む、皮膚性状の改善する方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009536121A JP5613417B2 (ja) | 2007-10-05 | 2008-10-03 | モルヒナン誘導体またはその薬理学的に許容される酸付加塩を有効成分とする皮膚性状改善治療薬 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007262015 | 2007-10-05 | ||
JP2007262015 | 2007-10-05 | ||
PCT/JP2008/068092 WO2009044883A1 (ja) | 2007-10-05 | 2008-10-03 | モルヒナン誘導体またはその薬理学的に許容される酸付加塩を有効成分とする皮膚性状改善治療薬 |
JP2009536121A JP5613417B2 (ja) | 2007-10-05 | 2008-10-03 | モルヒナン誘導体またはその薬理学的に許容される酸付加塩を有効成分とする皮膚性状改善治療薬 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2009044883A1 true JPWO2009044883A1 (ja) | 2011-02-10 |
JP5613417B2 JP5613417B2 (ja) | 2014-10-22 |
Family
ID=40526303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009536121A Expired - Fee Related JP5613417B2 (ja) | 2007-10-05 | 2008-10-03 | モルヒナン誘導体またはその薬理学的に許容される酸付加塩を有効成分とする皮膚性状改善治療薬 |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100222309A1 (ja) |
EP (1) | EP2196206B8 (ja) |
JP (1) | JP5613417B2 (ja) |
KR (1) | KR101173509B1 (ja) |
CN (1) | CN101848714B (ja) |
AU (1) | AU2008308005B2 (ja) |
BR (1) | BRPI0817804A8 (ja) |
CA (1) | CA2702032C (ja) |
ES (1) | ES2748274T3 (ja) |
MX (1) | MX2010003660A (ja) |
PL (1) | PL2196206T3 (ja) |
RU (1) | RU2440117C1 (ja) |
TW (1) | TWI453020B (ja) |
WO (1) | WO2009044883A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10131672B2 (en) * | 2010-01-29 | 2018-11-20 | Toray Industries, Inc. | Therapeutic or prophylactic agent for biliary diseases |
AU2011317183B2 (en) * | 2010-10-19 | 2016-10-20 | Memorial Sloan-Kettering Cancer Center | 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain |
CN103327977B (zh) | 2011-01-31 | 2016-05-04 | 东丽株式会社 | 恶液质的治疗或预防剂 |
CA2894971C (en) | 2012-12-14 | 2018-06-26 | Purdue Pharma L.P. | Nitrogen containing morphinan derivatives and the use thereof |
EP2941431B1 (en) | 2012-12-28 | 2017-10-25 | Purdue Pharma L.P. | Substituted morphinans and the use thereof |
EP4212532A3 (en) | 2015-04-30 | 2023-09-27 | Memorial Sloan Kettering Cancer Center | Mitragynine analogs and uses thereof |
CN105461727A (zh) * | 2015-12-01 | 2016-04-06 | 吕涛 | 一种纳呋拉啡的精制方法 |
WO2018160500A1 (en) | 2017-03-03 | 2018-09-07 | Ring Inc. | Solar-charging mounting bracket for audio/video recording and communication devices |
WO2019171333A1 (en) | 2018-03-08 | 2019-09-12 | Victoria Link Ltd | Treatment of demyelinating diseases |
US20230255955A1 (en) * | 2020-06-30 | 2023-08-17 | Toray Industries, Inc. | Ameliorating agent or prophylactic agent for muscle weakness symptom in disease or syndrome associated with metabolic disorder |
AU2022292554A1 (en) | 2021-06-14 | 2024-01-04 | Scorpion Therapeutics, Inc. | Urea derivatives which can be used to treat cancer |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4923875A (en) * | 1989-07-10 | 1990-05-08 | Baker Cummins Pharmaceuticals, Inc. | Method for treatment of mast cell-mediated dermatologic disorders |
JP2521853B2 (ja) | 1990-07-25 | 1996-08-07 | タカラベルモント株式会社 | 化粧料 |
ES2121988T3 (es) | 1992-01-23 | 1998-12-16 | Toray Industries | Derivado de morfinano y uso medicinal. |
WO1995003307A1 (fr) | 1993-07-19 | 1995-02-02 | Toray Industries, Inc. | Agent de protection de cellules cerebrales |
NZ268969A (en) * | 1993-07-23 | 1997-06-24 | Toray Industries | Morphinan derivatives and pharmaceutical compositions |
JPH07187990A (ja) | 1993-12-24 | 1995-07-25 | Toshiko Yamamoto | 化粧料 |
CN1291717C (zh) * | 1996-11-25 | 2006-12-27 | 东丽株式会社 | 止痒药物 |
US5834480A (en) | 1997-06-13 | 1998-11-10 | Elkhoury; George F. | Topical application of opioids for treatment of acne and sebaceous gland disorders |
WO1999005146A1 (fr) * | 1997-07-25 | 1999-02-04 | Toray Industries, Inc. | Remedes contre l'hyponatremie |
DE69830654T2 (de) | 1997-09-02 | 2006-05-04 | Toray Industries, Inc. | Heilmittel für die drogenabhängigkeit |
JP2000053572A (ja) | 1998-08-11 | 2000-02-22 | Toray Ind Inc | ORL1(opioid orphan)受容体拮抗薬 |
EP1219624B1 (en) | 1999-08-24 | 2008-07-09 | Toray Industries, Inc. | Remedies for neuropathic pain and model animals of neuropathic pain |
ES2319265T3 (es) | 2001-03-30 | 2009-05-06 | Toray Industries, Inc. | Farmacos para el sindrome de piernas inquietas. |
CA2451133C (en) | 2001-05-08 | 2012-09-18 | Toray Industries, Inc. | Therapeutic agent for sepsis |
JP2004107209A (ja) | 2002-09-13 | 2004-04-08 | Nippon Oruganon Kk | 掻痒治療薬 |
JP4499034B2 (ja) * | 2003-02-19 | 2010-07-07 | 久光製薬株式会社 | N−アリール又はn−ヘテロアリールピペラジン誘導体及びそれを含有する医薬 |
JP2004352714A (ja) | 2003-05-08 | 2004-12-16 | Kyorin Pharmaceut Co Ltd | 新規な4−(2−フロイル)アミノピペリジン誘導体 |
JP4381157B2 (ja) | 2004-02-03 | 2009-12-09 | 久光製薬株式会社 | 2,2−ジフェニル−1−エタノン誘導体及びそれを含有する医薬 |
ES2423004T3 (es) | 2005-03-10 | 2013-09-17 | Toray Industries, Inc. | Agente antiprurítico para el prurito provocado por la esclerosis múltiple |
CA2609985A1 (en) * | 2005-06-03 | 2007-05-10 | The University Of Chicago | Modulation of cell barrier dysfunction |
-
2008
- 2008-10-03 WO PCT/JP2008/068092 patent/WO2009044883A1/ja active Application Filing
- 2008-10-03 AU AU2008308005A patent/AU2008308005B2/en not_active Ceased
- 2008-10-03 BR BRPI0817804A patent/BRPI0817804A8/pt not_active IP Right Cessation
- 2008-10-03 EP EP08835121.8A patent/EP2196206B8/en not_active Not-in-force
- 2008-10-03 CN CN200880110176.5A patent/CN101848714B/zh not_active Expired - Fee Related
- 2008-10-03 MX MX2010003660A patent/MX2010003660A/es not_active Application Discontinuation
- 2008-10-03 US US12/680,908 patent/US20100222309A1/en not_active Abandoned
- 2008-10-03 ES ES08835121T patent/ES2748274T3/es active Active
- 2008-10-03 PL PL08835121T patent/PL2196206T3/pl unknown
- 2008-10-03 CA CA2702032A patent/CA2702032C/en not_active Expired - Fee Related
- 2008-10-03 TW TW097138034A patent/TWI453020B/zh not_active IP Right Cessation
- 2008-10-03 RU RU2010117649/15A patent/RU2440117C1/ru active
- 2008-10-03 KR KR1020107007134A patent/KR101173509B1/ko active IP Right Grant
- 2008-10-03 JP JP2009536121A patent/JP5613417B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2008308005B2 (en) | 2012-06-07 |
CN101848714B (zh) | 2014-08-20 |
MX2010003660A (es) | 2010-08-10 |
EP2196206B8 (en) | 2019-11-13 |
EP2196206A1 (en) | 2010-06-16 |
BRPI0817804A8 (pt) | 2017-04-18 |
KR20100049683A (ko) | 2010-05-12 |
WO2009044883A1 (ja) | 2009-04-09 |
JP5613417B2 (ja) | 2014-10-22 |
CA2702032C (en) | 2013-04-02 |
TW200927116A (en) | 2009-07-01 |
EP2196206A4 (en) | 2010-09-22 |
RU2440117C1 (ru) | 2012-01-20 |
BRPI0817804A2 (pt) | 2016-10-11 |
CA2702032A1 (en) | 2009-04-09 |
US20100222309A1 (en) | 2010-09-02 |
TWI453020B (zh) | 2014-09-21 |
AU2008308005A1 (en) | 2009-04-09 |
ES2748274T3 (es) | 2020-03-16 |
PL2196206T3 (pl) | 2020-02-28 |
EP2196206B1 (en) | 2019-07-17 |
KR101173509B1 (ko) | 2012-08-14 |
CN101848714A (zh) | 2010-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5613417B2 (ja) | モルヒナン誘導体またはその薬理学的に許容される酸付加塩を有効成分とする皮膚性状改善治療薬 | |
EP0897726B1 (en) | Antipruritic agent | |
EP0132346B1 (en) | Novel compounds and compositions useful for producing analgesia | |
US20030216413A1 (en) | Catecholamine pharmaceutical compositions and methods | |
US20120232136A1 (en) | Substance with sedative effect | |
JPH04500824A (ja) | 光老化の作用を回復させるための皮膚の治療方法 | |
EP0116538A1 (en) | Method of treating pruritis and composition therefor | |
BR102015011079A2 (pt) | palmitoiletanolamida em forma não micronizada, em forma micronizada (pea-m), em forma ultramicronizada (pea-um) ou misturas das mesmas e composição farmacêutica ou veterinária | |
US6440987B1 (en) | Antipruritic | |
EP2945627A1 (en) | Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands | |
WO2019093359A1 (ja) | 末梢毛細血管の血流量増加剤 | |
JPH11209285A (ja) | セラミド合成促進剤 | |
US20060088556A1 (en) | Topical formulation and use of buspirone | |
CZ2014416A3 (cs) | Využití substituovaných analogů alaptidu jako modifikátorů transdermální penetrace ve farmaceutických kompozicích pro humánní a veterinární aplikace | |
Roets | The transdermal absorption of drugs that are suitable for use against morning sickness during pregnancy | |
WO2013090986A1 (en) | Treatment of seborrhoea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110801 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110801 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130709 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130904 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140430 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140710 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20140711 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20140801 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140826 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140908 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5613417 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |